RT Journal Article ID 1c8039d21494e54a A1 Terlikowski, Slawomir A1 Sulkowska, Mariola A1 Nowak, Henryk F. T1 The Effect of Recombinant Human Tumor Necrosis Factor-a on Ehrlich Ascites Tumor Growth JF Journal of Environmental Pathology, Toxicology and Oncology JO JEP(T) YR 2002 FD 2002-03-01 VO 21 IS 1 OP 6 AB We studied the antitumor effect of recombinant human tumor necrosis factor-a (rh TNF-a) on the intraperitoneal (i.p.) growth of Ehrlich ascites tumor (EAT) in Swiss albino male mice. The animals were treated with i.p. injection of rh TNF-a in doses of 5, 7.5, or 10 mg three times a week for 2 weeks, respectively, starting on the 4th day after the EAT inoculation. The effect of the cytokine was evaluated based on the following parameters: total ascites volume, packed cell volume, total packed cell volume, inhibitory growth rate, cellular population of EAT, morphological EAT cell changes, and mean survival time (MST). Rh TNF-a in a dose of 5 amg had only a slight effect on MST and inhibitory growth rate (IGR). After a dose of 7.5 mg, an increased IGR (p < 0.01) was observed, but the animals did not live longer than the controls. After 7.5- and 10-mg doses (p < 0.001), the number of cells in EAT decreased significantly and enhanced cellular damage to EAT cells was found. In mice treated with 10 mg, a significant IGR (p < 0.001) was accompanied by enhancement of MST (p < 0.01). Although the 10 mg dose exerted a greater effect compared with the remaining doses, no complete regression was attained. PB Begell House LK https://www.dl.begellhouse.com/journals/0ff459a57a4c08d0,18179bf737097662,1c8039d21494e54a.html